Clinical Study
Prediction of Sustained Virological Response to Telaprevir-Based Triple Therapy Using Viral Response within 2 Weeks
Table 4
Area under the receiver operating characteristic curve according to significant predicting factors for sustained virological response.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
AUC, area under the receiver operating characteristic curve; CI, confidence interval; NR, no response; PEG-IFN, pegylated interferon; IL, interleukin; HCV, hepatitis C virus; RVR, rapid virological response. |